Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Longboard Pharmaceuticals Inc
(NQ:
LBPH
)
36.08
+0.54 (+1.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Longboard Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
Why Longboard Pharmaceuticals Stock Is Falling
January 03, 2024
Longboard Pharmaceuticals Inc (NASDAQ: LBPH) shares are trading lower by 11.3% to $22.26 Wednesday afternoon after the company announced that it commenced a $150 million underwritten public offering...
Via
Benzinga
Apple, Longboard Pharmaceuticals, Coinbase, Moderna, Tesla: Why These 5 Stocks Are On Investors' Radars Today
January 02, 2024
U.S. stocks experienced mixed results in Tuesday’s trading session. The Dow Jones index showed resilience, gaining around 25 points, a modest rise of 0.07% to 37,715.04. In contrast, the tech-heavy...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally
January 02, 2024
Longboard Pharmaceuticals is working on treatments for seizure disorders.
Via
Investor's Business Daily
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock
January 02, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
The Latest Analyst Ratings for Longboard Pharmaceuticals
October 24, 2023
Via
Benzinga
The Latest Analyst Ratings for Longboard Pharmaceuticals
June 27, 2023
Via
Benzinga
Crude Oil Down 2%; Tesla Deliveries Top Estimates
January 02, 2024
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded up 0.01% to 37,691.77 while the NASDAQ fell 1.78% to...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target
January 02, 2024
Tuesday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of...
Via
Benzinga
Why Is Longboard Pharmaceuticals (LBPH) Stock Up 175% Today?
January 02, 2024
With Longboard Pharmaceuticals delivering positive clinical trial data, LBPH stock soared on the positive therapeutic implications.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 02, 2024
Via
Benzinga
Dow Turns Higher; Anavex Life Sciences Shares Plunge
January 02, 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.13% to 37,739.18 while the NASDAQ fell 1.29% to 14,818.23. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 02, 2024
Shares of Longboard Pharmaceuticals, Inc.
Via
Benzinga
Neurology-Focused Longboard Pharmaceuticals' Stock Soars Over 200% Today - Here's Why
January 02, 2024
Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental
Via
Benzinga
Dow Down 100 Points; US Manufacturing PMI Falls In December
January 02, 2024
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.28% to 37,584.41 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 02, 2024
Via
Benzinga
Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)
January 02, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)
January 01, 2024
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy Volunteers
November 29, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community
November 21, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 02, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in November
November 01, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023
October 05, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023
September 19, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Participate in Three Upcoming Investor Conferences
August 31, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Present Data at Upcoming Medical Meetings
August 30, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Completes Enrollment of Phase 1b/2a PACIFIC Study Evaluating LP352 for the Treatment of Developmental and Epileptic Encephalopathies
August 23, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 03, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Present at Upcoming Investor Conferences
August 03, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023
June 26, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.